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The ﬁrst principle of the Calman–Hine report’s recommendations on cancer services was that all patients should have access
to a uniformly high quality of care wherever they may live. This study aimed to assess whether the uptake of chemotherapy
for colorectal cancer varied by hospital type in Scotland. Hospitals were classiﬁed according to cancer specialisation rather
than volume of patients. To indicate cancer specialisation, hospitals were classiﬁed as ‘cancer centres’, ‘cancer units’ and ‘non-
cancer’ hospitals. Colorectal cancer cases were obtained from cancer registrations linked to hospital discharge data for the
period January 1992 to December 1996. Multilevel logistic regression was used to model the binary outcome, namely whether
or not a patient received chemotherapy within 6 months of ﬁrst admission to any hospital. The results showed that patients
admitted ﬁrst to a ‘non-cancer’ hospital were less than half as likely to go on to receive chemotherapy as those ﬁrst admitted
to a cancer unit or centre (OR=0.28). This result was not explained by distance between hospital of ﬁrst admission and
nearest cancer centre, nor by increasing age or severity of illness. The study covers the period immediately preceding the
introduction of the Calman–Hine report in Scotland and should serve as a baseline for future monitoring of access to
specialist care.
British Journal of Cancer (2002) 87, 1221–1226. doi:10.1038/sj.bjc.6600640 www.bjcancer.com
ã 2002 Cancer Research UK
Keywords: cancer registration data; inequalities; cancer services; regression analysis; monitoring
The Calman–Hine report in England and Wales in 1995 (Calman
and Hine, 1995) and the Scottish version in 1996 (SCCAC, 1996)
recommended a new structure for cancer services. This structure
was based upon a hierarchy of expertise in cancer care reaching
from primary care through cancer units in district hospitals to
specialised cancer centres so that ‘care should be provided as close
to the patient’s home as is compatible with high quality, safe and
effective treatment’. The rationale was a growing body of evidence
indicating that outcomes in treatment of common and uncommon
cancers improve with specialisation (Hakama et al, 1989; Gillis and
Hole 1996; Selby et al, 1996; Hoffman et al, 1997; Schrag et al,
2000).
Whilst there is a consensus that centralisation of services has
unarguable advantages (Campbell et al, 1999), specialised centres
are more likely to be located in urban areas resulting in geographi-
cal inequality of distribution. Studies in the United States, France
and Scotland have all shown that patients from rural areas are less
likely to be treated in a specialist centre and to have poorer survival
rates (Launoy et al, 1992; Howard et al, 1995; Greenberg et al,
1988). Campbell et al (2000) indicated that distance from a cancer
centre might be a determining factor in survival. A more recent
study showed that this is likely to be partly because patients living
further from cities and associated cancer centres have more
advanced disease at diagnosis (Campbell et al, 2001). It is therefore
crucial that any increase in physical distance from specialised
services does not exacerbate inequalities in uptake of specialist care.
Both reports emphasised the need to monitor the achievement
of the proposed equalisation of access and its impact on treatment
and survival rates. This study aimed to assess whether the uptake of
chemotherapy for colorectal cancer in Scotland varied by type of
hospital of ﬁrst admission. Colorectal cancer was chosen as it is
one of the three most common cancers in both sexes in Scotland
(ISD, 2001). Although surgery is the single most effective treatment
for colorectal cancer, chemotherapy should be considered for both
adjuvant and palliative purposes and is considered here as a
process indicator of specialist care (SIGN, 1997; Moir, 1999).
During the early 1990s, chemotherapy was still relatively new,
and was likely to be more sensitive to variation in uptake than it
may be now. McLeod (1999) showed that from 1990 to 1994 in
Scotland the onsite provision of chemotherapy at hospital of ﬁrst
admission was signiﬁcantly positively associated with patients’ odds
of receiving chemotherapy. A further aim was to update the analy-
sis to the period immediately before the introduction of clinical
guidelines for colorectal cancer management (SIGN, 1997) and
the Calman–Hine recommendations so that it could serve as a
baseline study against which change could be monitored.
MATERIALS AND METHODS
Regression analysis was used to examine the effect of degree of
hospital specialisation on uptake of chemotherapy. The regression
model used a three-level hierarchy of patients nested within areas
within hospitals. The dependent variable was whether a patient
received chemotherapy within 6 months of ﬁrst admission.
Comparison with the study for 1990–94 was made using descrip-
tive statistics and adjusted odds ratios with 95% conﬁdence
intervals. The deﬁnitions of the variables are given below.
Patients
The analysis was based on the same data set for 1992–1996 as used
by Austin and Russell (2002). Scottish cancer registration records
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www.bjcancer.comfor all patients aged over 17 diagnosed between 1st January 1992
and 31st December 1996 (n=15299) formed the study population.
Their data were linked by computerised probability linking by the
Information and Statistics Division (ISD) Scotland to individual
episodes of care collected through the Scottish Morbidity Record
inpatient and day case form (SMR 01). SMR 01 details were
selected if they contained a diagnosis of colorectal cancer and were
within the time frame of 1 year pre-registration to 1-year post
registration.
To answer this speciﬁc research question and to fulﬁl the require-
ments of multilevel modelling a number of exclusions were necessary.
To permit comparison with the previous study by McLeod (1999),
several of the same deﬁnitions were used. Patients with no recorded
hospital admissions were excluded. Consistent with McLeod (1999),
6 months from date of ﬁrst hospital admission was taken as the peri-
od in which uptake of chemotherapy was recorded, as almost 90% of
patients who received chemotherapy did so within this period.
Patients admitted after the 30th June 1996 were therefore excluded
(n=1517). Of the remaining 11728 cases, those with no recorded
deprivation category (Depcat) (Carstairs and Morris 1991) or post-
code, patients who died on day of diagnosis and those treated in
an English hospital were excluded (214).
For the regression analysis there must be a sufﬁcient number of
cases within each level and category. Only 47 out of 4123 patients
aged 75 and more received chemotherapy and therefore all patients
aged 75 and over had to be excluded from the analysis. Similarly,
hospitals that admitted fewer than ﬁve colorectal patients in the 5-
year period were excluded (77 hospitals, 180 patients). The ﬁnal
data set used in the multilevel analysis contained 7303 cases.
Level of hospital specialisation
Three levels of cancer specialisation were deﬁned for the 48 Scot-
tish hospitals that treated ﬁve or more colorectal cancer patients
in the 5 year period: cancer centre, cancer unit and ‘non-cancer’
hospital. The Calman–Hine proposals identiﬁed the ﬁve cities of
Aberdeen, Dundee, Edinburgh, Glasgow and Inverness as cancer
centres and described the role of centres (highly specialised) and
cancer units (commoner cancers), but no formal administrative
classiﬁcation yet exists of which hospitals in Scotland are cancer
centres or units. After consultation with the Cancer Surveillance
Unit in ISD and other cancer experts, nine hospitals within the ﬁve
cities were identiﬁed as ‘cancer centres’. Using the Health Services
Cost Books (National Health Service in Scotland ISD, 1996), hospi-
tals coded as 01 (major teaching hospital), 02 (general hospitals),
11 and 12 (mixed speciality hospital with or without maternity)
but which were not already cancer centres were judged to be
‘cancer units’ (total 24 hospitals). The remaining 15 hospitals were
classed as ‘non-cancer’ hospitals. The expected journey of care for
colorectal cancer patients, as one of the commoner cancers, was
that they would usually be referred on to a cancer unit for
chemotherapy but might also be referred to a centre. Hospital of
ﬁrst admission was therefore used for the analysis of hospital effect,
and the process of onward referral was treated as integral to
whether or not chemotherapy was given.
Area level variables
Patients were grouped into geographical areas using postcode
sectors. The 7303 cases included in the analyses were resident in
848 areas and admitted to one of 48 hospitals. Depcat was used
as an area level deprivation measure (Carstairs and Morris 1991).
Depcat 1 was categorised as ‘most afﬂuent’, Depcat 2 and 3 as
‘mid-afﬂuent’, Depcat 4 and 5 ‘mid-deprived’ and Depcat 6 and
7 as ‘most-deprived’ quartile. Rurality was based on population
density per hectare (McLeod, 1999). Postcode sectors with density
56 were termed ‘rural’ whilst those 56 were ‘urban’.
Patient level variables
Age and sex were taken from the linked data. Co-morbidity was
coded as ‘none’, ‘one’, or ‘two or more’ admissions from any of
the relevant conditions (Austin and Russell 2002). Patient transfer
and waiting list cases were grouped together as ‘elective’ and all
others as ‘emergency’. Dukes’ staging, which would have been
the severity indicator of choice, was not available in cancer regis-
tration data at the time. Instead, ‘death within the ﬁrst 6
months’ was used as an indication of severity of illness (McLeod,
1999). Since the date of death was not included in the linked data,
days from diagnosis to death was used. Post hoc analysis of Dukes’
staging from the 1997 cancer registration data (which contained
staging for the ﬁrst time) was used to assess the likely percentages
of patients with different stages of cancer (Austin and Russell,
2002).
Clinical data
SIGN guidelines currently recommend adjuvant chemotherapy for
patients with stage C colorectal cancer, entry into randomised trials
for Dukes’ stage B, and palliative chemotherapy for all patients
with advanced or metastatic cancer. It is likely that in the early
1990s Dukes’ C was the only clear indication for chemotherapy.
The coding of chemotherapy (X35.2) in the cancer registration data
does not distinguish between adjuvant and palliative, and therefore
the presence or absence of surgery was included in an attempt to
make this distinction. Deﬁnitive potentially curative surgery was
deﬁned following consultations with a colorectal surgeon and refer-
ence to the published literature (Austin and Russell, 2002).
Regression analysis
In the regression model the data are hierarchical, in that patients
are nested within areas within hospitals. This is done to avoid
overestimation of the statistical signiﬁcance of explanatory variables
that may arise because the observations are not independent of one
another. The technique allows variation which occurs at the higher
levels (i.e. variation amongst postcode sectors or hospitals) to be
analysed separately from variation at the level of the patient.
Because the dependent variable was binary, logistic regression
was used to model the binary outcome, i.e. whether or not a
patient received chemotherapy. Models were estimated using
restricted iterative generalised least squares (Goldstein, 1995). The
effect of each variable upon the likelihood of receiving chemother-
apy was compared by conversion from a coefﬁcient to odds ratio
(OR).
From the results of the regression analysis, statistical signiﬁcance
was tested by dividing each estimate by its standard error, resulting
in a t-statistic. If the t-statistic was in excess of +1.96, the estimate
was judged signiﬁcantly different from zero at the 0.05 level.
RESULTS
Austin and Russell (2002) provide descriptive statistics from the
larger data set.
Before making the necessary exclusions, the full data set
contained 15299 cases. Of the 13245 cases with at least one hospi-
tal admission, 10.7% (1422) received chemotherapy. Of these
patients, 76.2% (1083) received deﬁnitive surgery within one year,
indicating that chemotherapy was provided on both adjuvant and
palliative bases.
The characteristics of the 7303 patients aged less than 75 years
are listed in Table 1. A total of 13.7% (999) patients received
chemotherapy within 6 months of ﬁrst admission. The majority
of all cases, 70.3% (5133), presented as elective admissions. As
would be expected from the nature of colorectal cancer most
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morbidity as deﬁned, 81% (5916) had no admissions for any of
the relevant conditions, 9.3% (680) had one admission and 9.7%
(707) had two or more admissions. Six thousand (82.2%) lived
beyond the deﬁned treatment period of 6 months from date of
diagnosis. Of those who died within the 6 month period
(n=1303), 8.7% died within 14 days from date of diagnosis and
29.5% within 90 days. Over half of the patients were classiﬁed as
rural (4307, 59%).
Only 3.8% (275) of patients were admitted to a ‘non-cancer’
hospital; 59.6% (4355) were admitted to a cancer unit and
36.6% (2673) to a cancer centre.
Before adjusting for the patient, area and hospital characteristics
there was signiﬁcant variation between hospitals in the percentage
of patients receiving chemotherapy. The variation between areas
was very small and non-signiﬁcant. Consequently, area was
removed as a level and the remaining analysis was carried out using
a two-level model of hospital and patient. After adjusting for the
explanatory variables in the two-level model, variation between
hospitals remained signiﬁcant. The effects of the patient, area
and hospital characteristics upon the likelihood of receiving
chemotherapy are shown in Table 2.
Patient effects
There was a large effect with increasing age despite the exclusion of
patients over 75 years. Patients aged 17–54 years were over four
and a half times more likely to receive chemotherapy than those
aged 65–74 years (OR=4.61, 95% CI 4.43, 4.79). There was no
signiﬁcant difference between males and females. Patients admitted
as emergencies were less likely to receive chemotherapy but the
difference was not signiﬁcant. Co-morbidity did not have a signiﬁ-
cant effect but patients who died within 6 months were
signiﬁcantly less likely to receive chemotherapy.
Recognising the limitations of co-morbidity and death within 6
months as indicators for disease severity, a post hoc analysis was
conducted on the comparable set of 1997 data, which for the ﬁrst
time contained Dukes’ staging (Austin and Russell, 2002). There
was no signiﬁcant variation in staging across age groups, indicating
that the decreased likelihood of receiving chemotherapy in older
patients was not directly explained by increased cancer severity.
Moreover the percentage with unknown staging did not increase
signiﬁcantly with age below the age bands of 75 and above.
However, the uptake of chemotherapy did. Taking only Dukes’
stage C as an indicator for chemotherapy (SIGN, 1997), the 1997
data showed that 27.5% of patients all patients were Dukes’ C
and 35.3% of these patients received chemotherapy. Looking at
the uptake of chemotherapy among Dukes’ C patients within each
age group, 82.1% of those aged 17–54 years, 61.6% of those aged
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Table 1 Study population: patient characteristics
Number of patients % patients
Hospital
Hospital of ﬁrst admission
Cancer centre 2673 36.6
Cancer unit 4355 59.6
‘Non-cancer’ hospital 275 3.8
Area
Rurality
Urban 2996 41.0
Rural 4307 59.0
Deprivation
Most-afﬂuent 384 5.3
Mid-afﬂuent 2736 37.5
Mid-deprived 2889 39.6
Most-deprived 1294 17.7
Patient
Sex
Female 3260 44.6
Male 4043 55.4
Age
17–54 years 1203 16.5
55–64 years 2239 30.6
65–74 years 3861 52.9
Comorbidity
No admissions 5916 81.0
One admission 680 9.3
Two or more admissions 707 9.7
Death within treatment period
Yes 1303 17.8
No 6000 82.2
Table 2 Effect of patient, area and hospital characteristics upon the likelihood of receiving chemotherapy
Adjusted
or
chemotherapy 95% CI
Hospital characteristics (baseline)
Classiﬁcation Cancer unit 0.59 (70.09, 1.26)
(cancer centre) ‘Non-cancer’ hospital 0.28* (1.93, 2.27)
Area characteristics
Deprivation Mid-afﬂuent quartile 0.87 (0.74, 1.00)
(most afﬂuent quartile) Mid-deprived quartile 0.82 (0.51, 1.13)
Most deprived quartile 0.55* (0.20, 0.90)
Rurality (rural) urban 1.25 (0.99, 1.51)
Patient characteristics
Age (65–74) 17–54 4.61* (4.43, 4.79)
55–64 2.10* (1.93, 2.27)
Sex (males) Females 0.99 (0.84, 1.14)
Admission (elective) Emergency 0.87 (0.70, 1.03)
Comorbidity (0) 1 1.26 (1.03, 1.50)
2 1.23 (1.00, 1.47)
Death within treatment period (no) Yes 0.69* (0.48, 0.91)
*Signiﬁcant result at 0.05 level.
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those aged over 75 years with Dukes’ C received chemotherapy.
Area effects
There was evidence of a deprivation effect as those in the most
deprived quartile were just over half as likely to receive chemother-
apy as those in the most afﬂuent quartile. Rurality did not have a
statistically signiﬁcant effect.
Hospital effects
There was a signiﬁcant effect with hospital classiﬁcation. Compared
to a cancer centre, patients admitted ﬁrst to a cancer unit or ‘non-
cancer’ hospital were less likely to receive chemotherapy although
this was signiﬁcant only for those admitted to a ‘non-cancer’
hospital. A post hoc analysis of the effect of distance was included
to explore whether this effect was explained by increasing distance
from hospital of ﬁrst admission to the nearest cancer unit or
centre. Distance was grouped as 595 km and 595 km (straight
line distance) and an interaction term with ‘non-cancer’ hospital
was included in the model. This interaction was not statistically
signiﬁcant indicating that distance did not appear to be a deter-
mining factor.
Onward referral from non-cancer hospital
There was expected to be a close correlation between uptake of
chemotherapy by ﬁrst admissions to a non-cancer hospital and
whether or not the patients were referred on to a cancer unit or
centre. Of the 275 patients (3.8%) admitted to a ‘non-cancer’
hospital, 201 (73%) had no further admissions for colorectal
cancer. Compared to those referred on, those not referred on
tended to be more deprived (56.2%) (w
2=10.539, P-value=0.014),
after merging the deprivation quartiles into ‘most afﬂuent’ and
‘most deprived’ (Table 3). Those not referred on also tended to
be younger with a lower proportion in the 65–74 year age group
(45.3%) (w
2=10.762, P-value=0.005). Therefore the difference
between referrals and non-referral is not explained by increasing
age although deprivation may be a factor. A greater proportion
of those not referred on died within the treatment period suggest-
ing greater disease severity as a reason for non-referral but this
difference was not signiﬁcant. We are unable to explain the varied
associations with chemotherapy found in this subgroup of patients.
Time trends
To give some indication of variation over time a direct comparison
was made to McLeod’s (1999) study based on the 1990–1994
cancer registration data (Table 4). In this analysis hospitals were
classiﬁed according to onsite availability of chemotherapy (45
recorded episodes of chemotherapy) and secondary diagnosis was
used as an indicator of comorbidity. The patient characteristics
were very similar in the analyses of the 1990–1994 and 1992–
1996 cancer registration data. The number of hospitals included
(59) was greater in 1990–1994 but a similar proportion of patients
was ﬁrst admitted to a hospital with onsite availability of
chemotherapy.
For all ages, the rate of chemotherapy uptake increased by 2.7%
from the 1990–1994 study, from 8% to 10.7%. In 1990–1994, as
in this study, a signiﬁcant negative effect was found for increasing
age and deprivation, and a positive effect of on site availability and
co-existent neoplasms. As there is a two year overlap between the
two studies similarities would be expected and their existence
supports the ﬁndings of both studies. Whilst the trend of signiﬁ-
cant results is largely similar, there are some interesting
differences in the size of effect between the two studies. The effect
of a secondary diagnosis of neoplasm increased from OR 1.99 to
OR 2.27, while there was a slight fall in the OR for deprivation
(from 0.73–0.55). The largest difference between the two studies
was in the size of effect of on site availability at hospital of ﬁrst
admission. In 1990–1994 patients who were ﬁrst admitted to a
hospital with on site availability were almost six times more likely
to receive chemotherapy than those admitted to a hospital with no
onsite availability (OR=5.67, CI 2.63–12.20). The effect was still
signiﬁcant in 1992–1996 but was greatly reduced (OR=2.88, CI
2.24–3.52). Patients from 1992–1996 were still almost three times
less likely to receive chemotherapy if they were not ﬁrst admitted
to a hospital with onsite chemotherapy. This follows the establish-
ment of the Scottish Cancer Therapy Network in 1993 and may
reﬂect more widespread appreciation of the beneﬁts of specialist
care and the role of non-surgical techniques in the treatment of
colorectal cancer.
DISCUSSION
The leading principle behind the Calman–Hine recommendations
is that all patients should have access to a uniformly high quality of
care in the community or hospital wherever they may live to
ensure maximum possible cure rates and best quality of life
(Calman and Hine, 1995). Since the time of the study data, the
emphasis has become more speciﬁcally on access to multidisciplin-
ary teams within hospitals rather than simply to specialist hospitals.
However, the labelling of specialists and teams is still a matter of
judgement, and our classiﬁcation of hospitals was based on know-
ledge of the health service and not on a set standard for level of
specialisation. Therefore, some hospitals may have been inappro-
priately classiﬁed. The results are encouraging however as they
discriminate well among the three types of hospital. Discussion
with oncologists has conﬁrmed that almost all the cancer units
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Table 3 Patients admitted to ‘‘non-cancer’’ hospitals
Patients referred on Patients not referred on
(%) (%) P-value
Age (years) 454 8 (10.8) 36 (17.9) 10.762
55–64 16 (21.6) 74 (36.8) (0.005)
65–74 50 (67.6) 91 (45.3)
Total 74 (100.0) 201 (100)
Death within Died 13 (17.6) 38 (18.9) 0.064
treatment period (0.800)
Deprivation Most afﬂuent 45 (60.8) 88 (43.8) 10.539
(0.014)
Most deprived 29 (39.2) 113 (56.2)
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non-cancer-hospitals. Thus the level of specialisation available by
hospital was relatively homogenous within the three categories
and discrete among them. It was not possible to analyse for differ-
ences between individual clinicians’ practice within units or
centres, but the classiﬁcation enabled a focus on whether or not
non-cancer hospitals were playing their part in onward referral
to specialist care as judged by type of hospital and uptake of
chemotherapy.
This analysis of routine cancer registration and hospital
discharge data has shown that patients admitted to a ‘non-cancer’
hospital were less likely to receive chemotherapy than those
admitted to a cancer unit or centre. At 3.8% of those aged less than
75, it is a relatively small proportion of all cancer patients to whom
this applies. However it involves 15 of the 48 hospitals in Scotland
that treat colorectal cancer patients and may indicate an important
problem associated with increased specialisation. Older patients
were also shown to be less likely to receive chemotherapy. The
low numbers of patients aged 75 or more who received chemother-
apy and evidence from Austin and Russell (2002) that shows older
age as a statistically signiﬁcant negative predictor for receiving
chemotherapy suggest that the effect may well be greater in those
patients over 74 years of age. It is therefore a possible inequity that
does not sit well with the principles of equal access to specialist
care embodied in the Calman–Hine report (Calman and Hine,
1995).
As in the study by Austin and Russell (2002), reasons for the
age and hospital effect would be largely speculative. More in-
depth, qualitative studies are needed to understand why older
patients and patients admitted to a ‘non-cancer’ hospital may
be less likely to go on to receive specialist cancer care. Previous
studies have shown patients living more remote from cities and
cancer centres have more advanced cancer at diagnosis and poorer
outcomes (Campbell 2000, 2001). This must not be compounded
by an inequity of access to specialist care. This study has provided
a possible method for monitoring access, a system of hospital
classiﬁcation and a baseline for future analysis that will be helped
by the inclusion of Dukes’ staging in future cancer registration
data.
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